Precision Psychiatry Market Outlook 2035
The global precision psychiatry market was valued at US$ 0.9 Billion in 2024 and is projected to reach US$ 4.2 Billion by the end of 2035, expanding at a CAGR of 14.2% from 2025 to 2035. Market growth is driven by the rising prevalence of mental health disorders, increasing adoption of personalized medicine, and advancements in genomics and neurobiology.
👉 Get sample market research report copy now@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86888
Market Overview
Precision psychiatry is an emerging approach in mental healthcare that focuses on personalized diagnosis and treatment based on an individual’s genetic, biological, environmental, and lifestyle factors. Unlike traditional “one-size-fits-all” psychiatric treatments, precision psychiatry aims to deliver targeted therapies that improve patient outcomes and reduce trial-and-error prescribing.
The growing integration of genomics, biomarkers, artificial intelligence (AI), and digital health technologies is revolutionizing the diagnosis and treatment of psychiatric disorders such as depression, schizophrenia, bipolar disorder, and anxiety disorders.
Analysis of Key Players in the Precision Psychiatry Market
The market is rapidly evolving, with key players focusing on AI-driven diagnostics, biomarker discovery, and personalized therapeutics.
Key companies operating in the market include:
- Assurex Health (Myriad Genetics)
• Genomind Inc.
• Tempus Labs, Inc.
• Mindstrong Health
• Holmusk
• Quartett Health
• Cerebra Health
• IBH Population Health Solutions
• NeuroFlow
• AiCure LLC
• Other Key Players
These companies are investing heavily in data analytics, pharmacogenomics testing, and digital mental health platforms to enhance clinical decision-making and patient care.
Key Developments in Global Precision Psychiatry Market
- July 2025: Polaris Genomics secured a USD 100K grant to advance its PTSD genomic test and accelerate commercialization.
- June 2025: GeneDx published SeqFirst study results in The Journal of Pediatrics, showing faster pediatric diagnosis through genomic testing.
- May 2025: GrayMatters Health launched Prism™ Suite, including a depression protocol using brain activity biomarkers.
- October 2024: Psyomics Ltd partnered with Priory Group to deploy the AI-based Censeo triage platform.
Analysts’ Viewpoint on the Global Precision Psychiatry Market
Industry analysts emphasize that the shift toward personalized and preventive mental healthcare is a major growth driver. Precision psychiatry is gaining traction due to its potential to improve treatment efficacy and minimize adverse drug reactions.
The rising burden of mental health disorders globally, coupled with increased awareness and reduced stigma, is further fueling market demand. Additionally, advancements in brain imaging, wearable technologies, and big data analytics are enhancing diagnostic accuracy.
North America currently leads the market due to strong healthcare infrastructure and research investments, while Asia Pacific is expected to witness the fastest growth driven by increasing healthcare access and awareness.
👉 Discuss Implications for Your Industry or Do you want customize Report, Please Request Sample Research Report PDF@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86888
Key Player Strategies
⚙️ Personalized Treatment Solutions
Development of patient-specific therapies
🧠 AI & Data Analytics Integration
Enhancing diagnosis and predictive capabilities
🧬 Genomics & Biomarker Research
Advancing precision medicine approaches
📱 Digital Mental Health Platforms
Expanding remote monitoring and telepsychiatry
🌍 Strategic Partnerships
Collaborations with healthcare and tech providers
Challenges
- High cost of genetic and diagnostic testing
• Limited awareness in developing regions
• Data privacy and ethical concerns
• Complexity in integrating multi-omics data
Opportunities
⚡ Rising Mental Health Awareness
Growing demand for effective treatment solutions
🧪 Advancements in Genomics
Improved identification of biomarkers
📊 Big Data & AI Expansion
Better predictive and diagnostic capabilities
🌱 Personalized Medicine Trend
Shift toward individualized treatment approaches
🏥 Expansion in Emerging Markets
Increasing healthcare investments and access
Market Segmentation
By Technology
- Genomics
• Neuroimaging
• Biomarkers
• AI & Machine Learning
By Application
- Depression
• Schizophrenia
• Bipolar Disorder
• Anxiety Disorders
• Others
By End-user
- Hospitals
• Psychiatric Clinics
• Research Institutes
• Telehealth Platforms
By Region
- North America – Advanced healthcare infrastructure
• Europe – Strong research and regulatory support
• Asia Pacific – Rapid growth and rising awareness
• Latin America
• Middle East & Africa
Why Invest in the Precision Psychiatry Market Outlook 2035
✅ High-growth market with strong CAGR of 14.2%
✅ Increasing demand for personalized mental healthcare
✅ Rapid advancements in AI, genomics, and digital health
✅ Growing global mental health burden
✅ Expanding opportunities in emerging markets
👉 To buy this comprehensive market research report, click here to inquire@ https://www.transparencymarketresearch.com/checkout.php?rep_id=86888<ype=S
FAQs
- What is the projected market size by 2035?
The market is expected to reach US$ 4.2 Bn by 2035. - What is the CAGR of the market?
The market is projected to grow at a CAGR of 14.2% from 2025 to 2035. - What factors are driving market growth?
Rising mental health disorders, advancements in genomics, and increasing adoption of personalized medicine. - Which region dominates the market?
North America dominates due to strong research and healthcare infrastructure. - What are key trends in the market?
AI integration, pharmacogenomics, digital psychiatry, and biomarker-based diagnostics.
About Us Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
Media Contact:
Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY – 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Media Inquiries: media@transparencymarketresearch.com
Sales Inquiries: sales@transparencymarketresearch.com
Leave a Reply